Skip to main content
Year archive

Torrent Pharmaceuticals Ltd. — 2023 filings

All 208 regulatory filings released by Torrent Pharmaceuticals Ltd. (TORNTPHARM) in 2023, sourced directly from the official regulator.

208 Filings
2023 Period
2023 filings (208)
Filing Released Lang
Updates
Regulatory Filings
2023-12-31 English
Disclosure u/r 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-12-30 English
Updates
Regulatory Filings
2023-12-28 English
Intimation Under regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-12-28 English
Intimation of the Closure of Trading Window
Regulatory Filings
2023-12-27 English
Trading Window
Regulatory Filings
2023-12-27 English
Loss of Share Certificates
Regulatory Filings
2023-12-19 English
Intimation of issue of duplicate share certificates
Regulatory Filings
2023-12-19 English
Partial redemption of NCDs issued under ISIN - INE685A07082
Regulatory Filings
2023-12-14 English
Redemption
Regulatory Filings
2023-12-14 English
Updates
Regulatory Filings
2023-12-12 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-12-12 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-12-06 English
Loss of Share Certificates
Regulatory Filings
2023-12-06 English
Copy of Newspaper Publication
Regulatory Filings
2023-12-06 English
Copies of Newspaper cuttings in connection with transfer of shares to IEPF
Regulatory Filings
2023-12-06 English
Outcome of Postal Ballot
Regulatory Filings
2023-11-27 English
Shareholders meeting
Regulatory Filings
2023-11-27 English
Scrutinizer''s Report on the Postal Ballot
Regulatory Filings
2023-11-27 English
Torrent and Zydus sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India
Regulatory Filings
2023-11-10 English
Press Release
Regulatory Filings
2023-11-10 English
Loss of Share Certificates
Regulatory Filings
2023-11-09 English
Intimation of Issue of Duplicate Share Certificates
Regulatory Filings
2023-11-09 English
Intimation of Credit Rating
Regulatory Filings
2023-11-01 English
Credit Rating
Regulatory Filings
2023-11-01 English
Copy of Newspaper Publication
Regulatory Filings
2023-10-27 English
Newspaper advertisement for completion of dispatch of Postal Ballot Notice.
Regulatory Filings
2023-10-27 English
Shareholders meeting
Regulatory Filings
2023-10-26 English
Copy of Postal Ballot Notice.
Regulatory Filings
2023-10-26 English
Transcript of conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2023
Regulatory Filings
2023-10-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-10-26 English
Financial Result Updates
Regulatory Filings
2023-10-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-10-23 English
Outcome of Board Meeting
Regulatory Filings
2023-10-23 English
Related Party Transactions
Regulatory Filings
2023-10-23 English
Investor Presentation
Regulatory Filings
2023-10-23 English
Investor presentation
Regulatory Filings
2023-10-23 English
Financial results for quarter and half year ended 30-sep-23
Regulatory Filings
2023-10-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-10-16 English
Post Quarterly Financial Result Conference Call with Investors / Analyst
Regulatory Filings
2023-10-16 English
Loss of Share Certificates
Regulatory Filings
2023-10-13 English
Intimation of Loss of Share certificates
Regulatory Filings
2023-10-13 English
Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2023 to consider and approve the Quarterly Unaudited Financial results of the Compan…
Regulatory Filings
2023-10-09 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2023 ,inter alia, to consider and approve We would like to inform ....
Regulatory Filings
2023-10-09 English
Board Meeting — Financial Results
Regulatory Filings
2023-10-09 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-10-04 English
Loss of Share Certificates
Regulatory Filings
2023-10-04 English
Change in Management
Regulatory Filings
2023-09-30 English
Intimation regarding Change in Senior Management Personnel of the Company
Regulatory Filings
2023-09-30 English
Intimation of the Closure of Trading Window
Regulatory Filings
2023-09-29 English
Trading Window
Regulatory Filings
2023-09-29 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-09-21 English
Loss of Share Certificates
Regulatory Filings
2023-09-21 English
Intimation of Issue of Duplicate Share Certificates
Regulatory Filings
2023-09-15 English
Loss of Share Certificates
Regulatory Filings
2023-09-15 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-09-14 English
Loss of Share Certificates
Regulatory Filings
2023-09-14 English
News Verification
Regulatory Filings
2023-09-01 English
Clarification / information on news item
Regulatory Filings
2023-09-01 English
Credit Rating
Regulatory Filings
2023-08-24 English
Intimation of Credit Rating
Regulatory Filings
2023-08-24 English
Press Release
Regulatory Filings
2023-08-24 English
Torrent Pharmaceuticals gets EIR from US FDA for Dahej facility
Regulatory Filings
2023-08-24 English
Updates
Regulatory Filings
2023-08-23 English
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-08-23 English
Updates
Regulatory Filings
2023-08-23 English
Loss of Share Certificates
Regulatory Filings
2023-08-19 English
Intimation of Loss of Share Certificate
Regulatory Filings
2023-08-19 English
Transcript of Conference call with Analysts / investors on financial results for the quarter ended 30th June, 2023 attached.
Regulatory Filings
2023-08-11 English
Loss of Share Certificates
Regulatory Filings
2023-08-09 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-08-09 English
Declaration of voting result and Scrutinizer Report
Regulatory Filings
2023-08-09 English
Shareholders meeting
Regulatory Filings
2023-08-08 English
Declaration of voting result
Regulatory Filings
2023-08-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-08-07 English
Audio Recording of Conference call with Analysts /Investors on Financial Results for the quarter ended 30th June, 2023 is attached
Regulatory Filings
2023-08-07 English
Appointment of Nikhil Khattau as an Independent Director of the Company
Regulatory Filings
2023-08-07 English
Alteration of Articles of Association of the Company
Regulatory Filings
2023-08-07 English
Appointment
Regulatory Filings
2023-08-07 English
Amendment to AOA/MOA
Regulatory Filings
2023-08-07 English
Pursuant to reg 30 of SEBI(LODR), 2015 we would like to inform that Company has commenced commercial operations of its new Oral Oncology facility at Bileshwarpura close to Indrad, Gujarat. ....
Regulatory Filings
2023-08-07 English
Updates
Regulatory Filings
2023-08-07 English
Proceeding of 50th Annual General meeting of the Company held on 07.08.2023
Regulatory Filings
2023-08-07 English
Shareholders meeting
Regulatory Filings
2023-08-07 English
Presentation to analyst on unaudited consolidated financial result for quarter ended 30.06.2023
Regulatory Filings
2023-08-07 English
Investor Presentation
Regulatory Filings
2023-08-07 English
Board has at its meeting held today approved, inter alia, the Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with ....
Regulatory Filings
2023-08-07 English
Press Release
Regulatory Filings
2023-08-07 English
Submission / Intimation u/r 30 of SEBI (LODR) Regulation, 2015 - Financial Result for quarter ended 30th June, 2023
Regulatory Filings
2023-08-07 English
Financial Result Updates
Regulatory Filings
2023-08-07 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-07-31 English
Loss of Share Certificates
Regulatory Filings
2023-07-31 English
Intimation of Issue of Duplicate Share Certificates
Regulatory Filings
2023-07-27 English
Loss of Share Certificates
Regulatory Filings
2023-07-27 English
Updates
Regulatory Filings
2023-07-20 English
In furtherance to our earlier intimation dated 31st July, 2021, we wish to inform you that the National Company Law Tribunal, Mumbai vide its order dated 22nd June, 2023, the certified ....
Regulatory Filings
2023-07-20 English
Loss of Share Certificates
Regulatory Filings
2023-07-19 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-07-19 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 7th August, 2023 at 06:00 P.M. to discuss the financial performance of the Company for the ....
Regulatory Filings
2023-07-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-07-19 English
Copy of Newspaper Publication
Regulatory Filings
2023-07-15 English
Please find enclosed herewith the copies of Newspaper cuttings published in Financial Express (English & Gujarati) on 15th July, 2023 in connection with the 50th Annual General Meeting ....
Regulatory Filings
2023-07-15 English
Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Compa…
Regulatory Filings
2023-07-15 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve the Audited Financial ....
Regulatory Filings
2023-07-15 English
Updates
Regulatory Filings
2023-07-15 English
Shareholders meeting
Regulatory Filings
2023-07-14 English
Updates
Regulatory Filings
2023-07-14 English
Updates
Regulatory Filings
2023-07-14 English
Submission of the Annual Report for the FY 2022-23 and the notice convening 50th Annual General Meeting of the Company
Regulatory Filings
2023-07-14 English
Pursuant to Regulation 34(2)(f) of SEBI Listing Regulations, please find enclosed herewith Business Responsibility and Sustainability Report (BRSR) for the FY 2022-23
Regulatory Filings
2023-07-14 English
Please find attached herewith soft copy of the Integrated Annual Report 2022-23 (comprising of Notice calling 50th Annual General Meeting (AGM) along with Audited Financial Statements, ....
Regulatory Filings
2023-07-14 English
Loss of Share Certificates
Regulatory Filings
2023-07-07 English
Intimation of issue of Duplicate Share Certificates
Regulatory Filings
2023-07-07 English
Copy of Newspaper Publication
Regulatory Filings
2023-07-06 English
Newspaper advertisement - Intimation of the 50th Annual General Meeting of the Company through Video-Conferencing / Other Audio Visual Means ("VC / OAVM") facility.
Regulatory Filings
2023-07-06 English
Loss of Share Certificates
Regulatory Filings
2023-07-03 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-07-03 English
Trading Window
Regulatory Filings
2023-06-29 English
Intimation of Closure of Trading Window as per Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons
Regulatory Filings
2023-06-29 English
Updates
Regulatory Filings
2023-06-15 English
We refer to our earlier letter dated 17-Mar-23 regarding USFDA Pre- Approval Inspection [PAI] of our Oral- Oncology manufacturing facility at Bileshwarpura, Gujarat. In furtherance ....
Regulatory Filings
2023-06-15 English
In continuation of our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference ....
Regulatory Filings
2023-06-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-06-03 English
In continuation to our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference ....
Regulatory Filings
2023-05-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-05-30 English
Related Party Transactions
Regulatory Filings
2023-05-30 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Friday, 23rd June, 2023 as the Record Date for taking record of the Members of the Company entitled for the purpose ....
Regulatory Filings
2023-05-30 English
Record Date
Regulatory Filings
2023-05-30 English
Investor Presentation
Regulatory Filings
2023-05-30 English
Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2023
Regulatory Filings
2023-05-30 English
Press Release
Regulatory Filings
2023-05-30 English
Board Recommended to the members a final dividend of ? 8/- (160%) per equity share of ? 5 each. The final dividend amount, if declared by the Shareholders, is proposed to be paid / dispatched ....
Regulatory Filings
2023-05-30 English
Board Recommended to the members to obtain enabling approval for issuance of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / ....
Regulatory Filings
2023-05-30 English
Date of payment of dividend
Regulatory Filings
2023-05-30 English
Board Recommended to the members a final dividend of ? 8/- (160%) per equity share of ? 5 each. The final dividend amount, if declared by the Shareholders, is proposed to be paid / dispatched ....
Regulatory Filings
2023-05-30 English
Board Recommended to the members a final dividend of ? 8/- (160%) per equity share of ? 5 each. The final dividend amount, if declared by the Shareholders, is proposed to be paid / dispatched ....
Regulatory Filings
2023-05-30 English
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")
Regulatory Filings
2023-05-30 English
Dividend
Regulatory Filings
2023-05-30 English
Financial Result Updates
Regulatory Filings
2023-05-30 English
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")
Regulatory Filings
2023-05-30 English
Updates
Regulatory Filings
2023-05-25 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-05-25 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-24 English
Pursuant to Regulation 24A(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 08-Feb-19 and BSE and ....
Regulatory Filings
2023-05-24 English
Scheme of Arrangement
Regulatory Filings
2023-05-18 English
We would like to inform that Hon''ble National Company Law Tribunal, Ahmedabad Bench ("NCLT"), vide its Order dated 17th May, 2023, has sanctioned the Scheme of Arrangement in the nature ....
Regulatory Filings
2023-05-18 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2023-05-17 English
Board Meeting — TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to consider and approve the Yearly Audited Financial results of the Company for…
Regulatory Filings
2023-05-17 English
Post Quarterly Financial Result Conference call with investors / analyst We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 30th May, 2023 ....
Regulatory Filings
2023-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-05-16 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings
2023-05-16 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve We would like to inform ....
Regulatory Filings
2023-05-16 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings
2023-04-26 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-26 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures ....
Regulatory Filings
2023-04-24 English
Redemption
Regulatory Filings
2023-04-24 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures ....
Regulatory Filings
2023-04-21 English
Redemption
Regulatory Filings
2023-04-21 English
With reference to the above, we enclose herewith copy of the Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 issued by RPAP & Co., Practicing Company Secretaries, ....
Regulatory Filings
2023-04-14 English
In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for ....
Regulatory Filings
2023-04-10 English
Loss of Share Certificates
Regulatory Filings
2023-04-07 English
Intimation of Loss of Share Certificates.
Regulatory Filings
2023-04-07 English
Trading Window
Regulatory Filings
2023-03-30 English
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading ....
Regulatory Filings
2023-03-30 English
Loss of Share Certificates
Regulatory Filings
2023-03-27 English
Intimation of Loss of Share Certificates.
Regulatory Filings
2023-03-27 English
Loss of Share Certificates
Regulatory Filings
2023-03-17 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-03-17 English
Updates
Regulatory Filings
2023-03-17 English
The USFDA conducted Pre-Approval Inspection [PAI] of our Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat from 13-Mar-23 to 17-Mar-23. At the end of the inspection, we ....
Regulatory Filings
2023-03-17 English
Copy of Newspaper Publication
Regulatory Filings
2023-03-16 English
Newspaper advertisement in respect of Notice of Hearing of Petition Ref : Scheme of Arrangement in the nature of Amalgamation of Curatio Health Care (I) Private Limited with Torrent ....
Regulatory Filings
2023-03-16 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-02-15 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-02-15 English
Loss of Share Certificates
Regulatory Filings
2023-02-03 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-02-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-02-01 English
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December, 2022
Regulatory Filings
2023-02-01 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-01-27 English
Loss of Share Certificates
Regulatory Filings
2023-01-27 English
In continuation of our letter dated 12-Jan-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference ....
Regulatory Filings
2023-01-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-01-25 English
Presentation to analysts on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2022
Regulatory Filings
2023-01-25 English
Investor Presentation
Regulatory Filings
2023-01-25 English
Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Regulatory Filings
2023-01-25 English
Press Release
Regulatory Filings
2023-01-25 English
Date of payment of dividend
Regulatory Filings
2023-01-25 English
Dividend Updates
Regulatory Filings
2023-01-25 English
Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Regulatory Filings
2023-01-25 English
Financial Result Updates
Regulatory Filings
2023-01-25 English
Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Regulatory Filings
2023-01-25 English
Dividend
Regulatory Filings
2023-01-25 English
Updates
Regulatory Filings
2023-01-24 English
This is with respect to our earlier communication on September 28, 2022 regarding the USFDA inspection at our manufacturing facility at Indrad, Gujarat and issuance of Form 483 by USFDA ....
Regulatory Filings
2023-01-24 English
Loss of Share Certificates
Regulatory Filings
2023-01-20 English
Intimation of Loss of Share Certificate
Regulatory Filings
2023-01-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-01-12 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th January, 2023 at 05:30 P.M. to discuss the financial performance of the Company for the ....
Regulatory Filings
2023-01-12 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Friday, 3rd February, 2023 as the Record Date for taking record of the Members of the Company for the purpose of ....
Regulatory Filings
2023-01-12 English
Record Date
Regulatory Filings
2023-01-12 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings
2023-01-12 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 ,inter alia, to consider and approve We would like to inform ....
Regulatory Filings
2023-01-12 English
Copy of Newspaper Publication
Regulatory Filings
2023-01-10 English
Newspaper advertisement in respect of the transfer of shares to IEPF
Regulatory Filings
2023-01-10 English
Loss of Share Certificates
Regulatory Filings
2023-01-05 English
Intimation of Loss of Share Certificate
Regulatory Filings
2023-01-05 English